Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancerJan Harder, Michael Geißler, Gabriele Ihorst et al.|British Journal of Cancer|2012Cited by 184
<i>TFAP2E–DKK4</i> and Chemoresistance in Colorectal CancerMatthias Ebert, Roland M. Schmid, Rupert Langer et al.|New England Journal of Medicine|2012Cited by 184
HER2/neu testing in primary colorectal carcinomaBarbara Ingold Heppner, Christoph Röcken|British Journal of Cancer|2014Cited by 169
Caveats of caveolin-1 in cancer progressionElke Burgermeister, Matthias Ebert, Mordechai Liscovitch et al.|Cancer Letters|2008Cited by 140
Genotypic and Phenotypic Characterization of Side Population of Gastric Cancer Cell LinesRosa Schmuck, Christoph Röcken|American Journal Of Pathology|2011Cited by 61